CD105+ cells displayed tumor-initiating activity, and as few as 100 cells could generate serially transplantable carcinomas in immunodeficient mice containing few CD105+ tumorigenic cells and a large number of differentiated CD105− cells. This evidence concerns the gene ENG and carcinoma.